Castle Biosciences Posts Strong Q2 Results with Impressive Revenue Surge
Castle Biosciences, Inc. has reported amazing results for the second quarter of 2024, showing a remarkable 74% increase in revenue, reaching $87 million. This growth is due to higher prices and more customers buying their tests.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
